Examkin

Question

Difficulty: Very hardHematology and Oncology

A 68-year-old woman is admitted to the hospital with profound fatigue, exertional dyspnea, and tingling in her toes. Laboratory studies reveal a hemoglobin of 5.8 g/dL5.8\text{ g/dL}, a mean corpuscular volume (MCV) of 122 fL122\text{ fL}, and a platelet count of 105,000/μL105,000/\mu\text{L}. A peripheral blood smear demonstrates macro-ovalocytes and neutrophils with six to seven nuclear lobes. The patient is diagnosed with severe cobalamin (vitamin B12B_{12}) deficiency secondary to pernicious anemia, and daily intramuscular cyanocobalamin therapy is initiated.

Arrange the following anticipated clinical and hematologic responses in the correct chronological order of their occurrence, from earliest to latest.

  1. 1Intracellular shift of potassium leading to potential hypokalemia
  2. 2Peak elevation of the peripheral blood reticulocyte count
  3. 3Clearance of hypersegmented neutrophils from the peripheral smear
  4. 4Normalization of the hemoglobin concentration
  5. 5Complete normalization of the mean corpuscular volume (MCV)

Answer

The correct chronological sequence is: Intracellular shift of potassium (1-2 days) → Peak elevation of reticulocyte count (5-8 days) → Clearance of hypersegmented neutrophils (10-14 days) → Normalization of hemoglobin concentration (4-8 weeks) → Complete normalization of MCV (3-4 months).
The physiological response to cobalamin replacement follows a strict timeline dictated by cellular kinetics. Marrow conversion and the resulting intracellular potassium shift occur first (1-2 days). This allows for the production and release of reticulocytes, which peak shortly after (5-8 days). As normal hematopoiesis resumes, the preexisting hypersegmented neutrophils die off according to their short lifespan (10-14 days). Hemoglobin levels gradually build up over several weeks (4-8 weeks). Finally, because the large, abnormal red blood cells produced before treatment survive for 120 days, the MCV takes the longest to normalize (3-4 months).

Step-by-Step Solution

1
Identify the earliest metabolic change resulting from bone marrow conversion.
Intracellular shift of potassium leading to potential hypokalemia.
Initiation of cyanocobalamin triggers immediate proliferation of hematopoietic precursors. This rapid cell division requires massive cellular uptake of potassium, occurring within the first 24-48 hours.
2
Identify the earliest peripheral blood evidence of new red blood cell production.
Peak elevation of the peripheral blood reticulocyte count.
As new erythrocytes are manufactured, reticulocytes enter the bloodstream. This count begins to rise by day 3 and peaks between days 5 and 8.
3
Determine the timeline for the disappearance of abnormal leukocyte morphology.
Clearance of hypersegmented neutrophils from the peripheral smear.
Circulating hypersegmented neutrophils must complete their natural lifespan (a few days) before they are entirely replaced by normal neutrophils, which typically takes 10 to 14 days.
4
Determine the timeline for the restoration of normal oxygen-carrying capacity.
Normalization of the hemoglobin concentration.
Hemoglobin rises steadily at a rate of approximately 1 g/dL1\text{ g/dL} per week, requiring 4 to 8 weeks to reach the normal reference range.
5
Determine the timeline for the clearance of all previously formed abnormal red blood cells.
Complete normalization of the mean corpuscular volume (MCV).
Because red blood cells live for 120 days, the macrocytic cells produced prior to therapy remain in circulation for months. The MCV will not fully normalize until these older cells have all undergone senescence (up to 3-4 months).

Key Concept

Timeline of physiologic and hematologic responses to cobalamin replacement in severe megaloblastic anemia
Rate this question

Topics

Hematology and Oncology

More questions from this topic